Federal Assistance Programs

The federal government offers multiple avenues for people with diabetes to access insulin at reduced or no cost. These programs form the backbone of subsidized insulin access in the United States. Knowing each program’s eligibility rules, enrollment periods, and coverage details is essential to maximizing the financial relief available.

Medicaid

Medicaid is a joint federal and state program that covers low-income individuals, families, children, pregnant women, elderly adults, and people with disabilities. Diabetes care—including insulin, syringes, test strips, and glucose monitors—is a mandatory benefit for all state Medicaid programs. However, formularies, prior authorization rules, and quantity limits vary by state. Many states now offer at least one insulin product on their preferred drug list with a copay of $3 or less for qualified enrollees. Eligibility is based on income relative to the federal poverty level (FPL)—typically 138% of FPL in expansion states. To apply, visit your state’s Medicaid agency website or use the federal HealthCare.gov Medicaid page to check your eligibility and start an application. In some states, you can apply online and receive provisional coverage the same day if you meet income criteria. For those living in states that have not expanded Medicaid, income thresholds can be much lower, and alternative assistance programs may be necessary.

Medicare

Medicare provides insulin coverage through Part D (prescription drug plans) and, in some cases, through Part B (durable medical equipment) when an insulin pump is used. As of 2024, the Inflation Reduction Act caps the out-of-pocket cost of a month’s supply of insulin for Medicare Part D beneficiaries at $35. This cap applies to both original Medicare Part D plans and Medicare Advantage plans that include drug coverage. Beneficiaries using an insulin pump with Part B coverage continue to pay 20% of the Medicare-approved amount for the pump and insulin (subject to Part B deductible). Annual enrollment runs from October 15 to December 7. Use Medicare Plan Finder to compare plan insulin costs. If your current plan’s insulin copay exceeds $35, consider switching during open enrollment. Also note that some Medicare Part D plans may charge more than $35 for insulin if you are in the coverage gap (donut hole)—the Inflation Reduction Act eliminates that by capping the copay at $35 throughout the year. Additionally, if you are a veteran, TRICARE or VA health benefits may provide even lower costs; check with the Department of Veterans Affairs for integrated enrollment.

Affordable Care Act Marketplace Plans

Health plans offered through the Affordable Care Act (ACA) Marketplace must cover prescription drugs as an essential health benefit, and insulin is almost always included. Premium tax credits and cost-sharing reductions are available based on household income, which can significantly lower monthly premiums and out-of-pocket costs. For example, a Silver-tier plan with cost-sharing reductions may cap the deductible and reduce copays for covered insulin to around $10–$20 per prescription, depending on the plan tier. Open enrollment typically runs from November 1 to January 15 in most states; special enrollment periods can be triggered by qualifying life events such as loss of other coverage, marriage, or birth of a child. Go to HealthCare.gov to apply or find your state-based marketplace. Be sure to review the drug formulary for any plan you consider—make sure the brand and dosage of insulin are covered. Some Marketplace plans also partner with pharmaceutical savings programs, so ask the insurer directly about any extra discounts.

State and Local Assistance Programs

Beyond federal programs, many states have enacted their own insulin affordability laws and assistance initiatives. These programs often fill gaps left by federal coverage and can provide immediate relief for residents who do not qualify for Medicaid or Medicare.

State Insulin Copay Caps

Since 2020, more than 20 states have passed laws capping copayments for insulin. Typical caps range from $25 to $100 per 30-day supply, but rules vary. Some states apply the cap only to state-regulated commercial insurance plans; others extend it to uninsured residents through state-funded programs. Examples include Colorado (cap of $25 per month for people with commercial insurance and up to $50 for uninsured through a state program), Illinois ($35 per month for commercial plans and a state-funded program for uninsured residents), and Maine ($35 per month for commercial insurance). Check your state’s department of insurance website for the current cap amount and which insurance types are eligible. Many states update their caps annually, so recheck each year. Some states, like New Mexico and Washington, have also expanded caps to cover deductibles, meaning you pay no more than the cap even before meeting your deductible.

State Prescription Assistance Programs (SPAPs)

Several states operate State Prescription Assistance Programs that provide free or deeply discounted insulin to low- and moderate-income residents. These programs are separate from Medicaid and often cover people who exceed Medicaid income limits but still lack affordable coverage. For instance, New York’s Elderly Pharmaceutical Insurance Coverage (EPIC) program covers insulin for seniors with incomes up to $75,000 (single) or $100,000 (couple). Minnesota’s RxConnect helps residents find pharmaceutical patient assistance programs. Income thresholds usually range from 200% to 300% of the FPL. Applications are handled by the state pharmacy assistance office or the state department of health. Some SPAPs require enrollment in a Medicare Part D plan first, so check requirements. Other notable SPAPs include those in Pennsylvania (PACE/PACENET) and Massachusetts (MassHealth Rx). Always apply to SPAPs even if you think your income is too high; some programs use adjusted income after medical expenses.

State-Funded Insulin Distribution Programs

Certain states have established direct distribution programs to provide insulin at no cost or very low cost to residents without insurance. California’s CalRx Diabetes Program (launched in 2024) allows the state to manufacture and distribute generic insulin, with plans to offer vials for $30 and pen packs for $55, regardless of insurance status. Washington State’s Insulin Safety Net Program provides a 30-day emergency supply of insulin for $35 to residents who have lost or changed coverage. Michigan’s Insulin Assistance Program offers a 30-day supply for $50 for uninsured residents with incomes up to 400% of FPL. These programs are typically accessed through participating local pharmacies or state health department hotlines. Some require pre-registration or a prescription from a participating provider. Additionally, states like Oregon and Nevada have launched pilot programs that partner with community clinics to distribute low-cost insulin directly to patients.

Patient Assistance Programs and Pharmaceutical Support

While not government-run, pharmaceutical patient assistance programs (PAPs) are heavily regulated and often partner with state and federal agencies to supply free insulin. The American Diabetes Association maintains an updated list of manufacturer PAPs, including those from Eli Lilly, Novo Nordisk, and Sanofi. As of 2024, many of these programs have simplified income verification and now offer lowered copay caps. For example, Sanofi’s Insulins Valyou Savings Program caps the cost of a 30-day supply at $35 for eligible uninsured or underinsured patients. Novo Nordisk’s My$99Insulin program offers a 30-day supply for $99 (or less with a copay card) for certain insulins. Eli Lilly’s Lilly Insulin Value Program allows eligible patients to pay no more than $35 per month for Lilly insulins. Apply directly through the manufacturer’s patient assistance portal or via NeedyMeds, which provides easy-to-follow application instructions and downloadable forms. You can also use the American Diabetes Association Insulin Affordability page for a comprehensive directory of current programs.

Copay Cards and Savings Programs

Even individuals with commercial insurance may qualify for manufacturer copay savings cards. These cards reduce out-of-pocket costs at the pharmacy and can be used in tandem with insurance. For instance, the Lilly Insulin Value Program provides savings such that eligible patients pay no more than $35 per month for Eli Lilly insulins. Most cards require you to have commercial insurance and not be enrolled in a government program like Medicare or Medicaid. Print the card from the manufacturer’s website and present it at the pharmacy each month. Some cards have an annual maximum benefit (e.g., up to $2,000 per year), so track your usage. Keep in mind that using a copay card may affect your deductible and out-of-pocket maximum, so consult with your insurance plan if you have questions. Additionally, some pharmacies like Costco and Walmart offer discounted insulin prices for uninsured patients under their own savings programs, which can be stacked with coupons from GoodRx or SingleCare.

Community Health Centers and Free Clinics

Local Federally Qualified Health Centers (FQHCs) and free clinics offer sliding-scale fees based on income. Many maintain on-site pharmacies with access to discounted insulin through the 340B Drug Pricing Program. The 340B program allows participating hospitals and health centers to purchase insulin at deeply reduced prices and pass those savings to patients. To find an FQHC near you, use the HRSA Health Center Locator. Walk-in appointments are often available, and staff can help you apply for government assistance programs on-site. Some health centers also have certified diabetes educators who can provide self-management training. Fees are typically based on a sliding scale; even uninsured patients can receive insulin for as little as $5–$20 per prescription. Many FQHCs also offer pharmacy delivery services for homebound patients, making it easier to maintain consistent access.

Emergency Insulin Access Programs

For those facing an immediate crisis—such as a sudden loss of insurance, a natural disaster, or a gap in coverage—several emergency programs provide a short-term supply of insulin at minimal cost. Insulin for Life USA is a nonprofit that distributes donated insulin via healthcare providers and clinics. HealthWell Foundation and Patient Advocate Foundation offer copay assistance grants for people with chronic conditions, including diabetes. These grants can be used specifically for insulin and are awarded on a first-come, first-served basis. Apply directly on their websites. Additionally, some state health departments maintain an Emergency Insulin Supply Program; for example, Washington State and California have dedicated hotlines for 30-day emergency supplies. If you are in crisis, call your local health department or a diabetes hotline (e.g., the American Diabetes Association at 1-800-DIABETES) for immediate guidance. Some hospital emergency rooms also stock insulin for urgent needs; ask to speak with a social worker or case manager during your visit.

How to Apply for Multiple Programs Simultaneously

Because eligibility criteria vary, it is often wise to apply for multiple assistance streams at once. Here is a step-by-step approach:

  1. Verify your income and household size. Most programs use FPL percentages. Gather tax returns, pay stubs, bank statements, and Social Security award letters.
  2. Check your state’s Medicaid website. Apply for Medicaid first, as it can unlock other benefits. Many states allow online applications with same-day provisional coverage if you meet the income test.
  3. If enrolled in Medicare Part D, confirm that your plan’s insulin copay is $35 or less under the Inflation Reduction Act cap. If not, consider switching during open enrollment (October 15–December 7).
  4. Search for manufacturer PAPs or copay cards using the American Diabetes Association’s online tool or NeedyMeds. Complete one or two applications per month to avoid delays; most require mailing or uploading a prescription and income proof.
  5. Contact your local FQHC for help with multiple applications; some centers employ enrollment specialists who can submit forms for several programs in one visit. They may also provide a 30-day emergency supply while applications are pending.
  6. Reapply annually or whenever your income or insurance changes. Many programs require recertification every 12 months. Set a calendar reminder 60 days before expiration.

Important Considerations and Limitations

While these programs greatly improve affordability, they come with caveats. Government programs often have restricted formularies; you may need to switch to a specific brand of insulin to receive the benefit. For example, a state Medicaid plan may only cover one brand of long-acting insulin. Ask your healthcare provider if a therapeutic substitution is safe for you. Additionally, copay caps for commercial insurance do not apply to high-deductible health plans that require you to meet the deductible first—unless state law specifically overrides that. Always verify with your insurer and pharmacist that the insulin you use is covered on your plan’s tier and that the copay reflects any applicable cap. Be aware of income cliffs: a small increase in income could disqualify you from Medicaid or PAPs, but you may then qualify for ACA subsidies. Re-evaluate your options each year during open enrollment periods. Finally, do not ration insulin—if you cannot afford your current supply, contact your doctor or a social worker immediately; emergency programs exist precisely for that situation. Keep a written record of every application and deadline, and store copies of all correspondence in a dedicated folder, whether physical or digital.

Access to affordable insulin is a right, not a privilege. By combining federal assistance, state programs, manufacturer savings, and community resources, you can drastically lower your monthly expenses. Start by checking your eligibility for the programs described above, and do not hesitate to ask a social worker, pharmacist, or diabetes educator for help navigating the forms. With consistent effort and annual re-evaluation, no one should have to ration or go without life-saving insulin.